PLUS THERAPEUTICS Inc. is a clinical-stage pharmaceutical company focused on developing innovative nanomedicine products for the treatment of cancer. With a strong emphasis on personalized medicine, the company aims to revolutionize cancer therapies through targeted drug delivery and enhanced patient outcomes.
Notification